Planar Hydrogel Microwell Layout for Viable Islet Transplantation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing islet transplantation methods face challenges such as poor viability and limited long-term function due to inadequate nutrient and oxygen supply, diffusion-limited transport, and slow angiogenesis, leading to hypoxia and tissue necrosis in encapsulated islets.

Innovation Solution

A planar biocompatible hydrogel-based macrodevice with a waffle-inspired design featuring interconnected microwells and immuno-isolatory hydrogel components, allowing for controlled spatial distribution of toroid-shaped microtissues and optional vascular-inductive cells, promoting efficient nutrient exchange and vascularization.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If encapsulated islets are transplanted using conventional methods, then immunological protection is achieved, but nutrient and oxygen supply becomes diffusion-limited leading to poor viability

Engineering Contradiction:
Improveislet viabilityVSAvoidnutrient and oxygen supply
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The macrodevice is segmented into multiple microwells arranged in a grid pattern, with each microwell containing a single microtissue. This segmentation creates numerous small compartments that reduce the diffusion distance for nutrients and oxygen, ensuring adequate supply to each microtissue while maintaining overall device function

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention transitions from conventional 3D encapsulated islets to a 2D planar macrodevice with interconnected microwells. This dimensional change creates a flattened structure with reduced diffusion paths, allowing efficient nutrient and oxygen transport across the entire device area while maintaining immunological protection

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If high cell packing density is used to achieve sufficient therapeutic dosage, then therapeutic efficacy is improved, but mass transfer is limited leading to hypoxia and tissue necrosis

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidhypoxia and tissue necrosis
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

Each microwell is designed with specific local characteristics including controlled size, shape, and spacing to optimize mass transfer. The local environment in each micrawell provides adequate nutrient and oxygen supply while maintaining high overall cell density, preventing hypoxia and tissue necrosis

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The hydrogel material used in the macrodevice possesses porous characteristics that facilitate mass transfer. The interconnected micrawell structure creates pathways for efficient nutrient and oxygen diffusion throughout the device, supporting high cell packing density without causing hypoxia

Inventive Principle:
Principle #31Porous materials

3Ease of manufacture

If native vasculature is lost after islet isolation, then transplantation is simplified, but oxygen and nutrient supply becomes insufficient leading to tissue necrosis

Engineering Contradiction:
Improvetransplantation simplicityVSAvoidoxygen and nutrient supply
Core Design Contradiction:
Ease of manufactureVSQuantity of substance

Solution Approach 1:

The macrodevice is pre-designed with vascular-inductive cells incorporated into the hydrogel matrix before transplantation. This preliminary action prepares the device to actively promote angiogenesis upon implantation, ensuring adequate oxygen and nutrient supply without complicating the transplantation procedure

Inventive Principle:
Principle #10Preliminary action

4Object-affected harmful factors

If encapsulated islets are used to protect from immune attack, then immunological safety is achieved, but long-term function is limited due to poor diffusion

Engineering Contradiction:
Improveimmunological protectionVSAvoidlong-term function
Core Design Contradiction:
Object-affected harmful factorsVSDuration of action of stationary object

Solution Approach 1:

The device segments the encapsulated tissue into multiple small microwells, each maintaining viable islet function through improved diffusion. This segmentation allows long-term survival and function of encapsulated islets while preserving immunological protection

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The macrodevice uses composite hydrogel materials that provide both immunological protection and enhanced mass transfer properties. The hydrogel composition is optimized to balance protection from immune attack with sufficient nutrient and oxygen diffusion for long-term islet function

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances microtissue viability and function by ensuring uniform distribution and proximity to vascular support, improving glucose responsiveness and insulin secretion, while maintaining structural integrity and mechanical stability.

Implementation Method 1

a component comprising an interconnected network of cross-linked hydrogel, which serves as dividing sidewalls separating evenly spaced microwells... therapeutic microtissues in an immuno-isolatory hydrogel that, when cross-linked, are entrapped in the micrawells... wherein said immuno-isolatory hydrogel component of b) interlocks with the interconnected hydrogel network component of a)

Methodology Applied
Scientific EffectCross-linking: Chemical Bonding

Data Source

PatentUS20260077105A1Therapeutic hydrogel device
Publication Date: 2026.03.19 NANYANG TECH UNIV
  • US20260077105A1 patent drawing
  • US20260077105A1 patent drawing
  • US20260077105A1 patent drawing

AI summary

The present invention generally relates to a therapeutic hydrogel device. More particularly, the present invention describes various embodiments of a hydrogel macrodevice, such as a planar hybrid hydrogel macrodevice that can achieve spatially controlled distribution of microtissues and support establishment of intra-device vasculature for enhanced cell survival, and individually encapsulated microtissues, and methods of use.